Showing results (121-130 of 157) with videos related to
Sort By:
Pageof 16
The New England Journal of Medicine|June 4, 2019
Maintenance Olaparib for Germline <i>BRCA</i>-Mutated Metastatic Pancreatic CancerTalia Golan, Pascal Hammel, Michele Reni, et al.Nature Medicine|October 19, 2025
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trialTimothy A Yap, David J Kwiatkowski, Ibiayi Dagogo-Jack, et al.The Lancet. Oncology|March 25, 2015
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trialLee M Krug, Hedy L Kindler, Hilary Calvert, et al.Annals of Surgical Oncology|June 25, 2025
Consensus Guideline for the Management of Peritoneal MesotheliomaLeanne M Brown, Sarah G Wilkins, Varun V Bansal, et al.Cancer|June 25, 2025
Consensus guideline for the management of peritoneal mesotheliomaLeanne M Brown, Sarah G Wilkins, Varun V Bansal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2011
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303Federico Innocenti, Kouros Owzar, Nancy L Cox, et al.Annals of Surgical Oncology|August 17, 2019
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II TrialAlice C Wei, Fang-Shu Ou, Qian Shi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2020
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> MutationEileen M O'Reilly, Jonathan W Lee, Mark Zalupski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2018
Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance)Temidayo Fadelu, Sui Zhang, Donna Niedzwiecki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2016
Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid TumorsSaoirse O Dolly, Andrew J Wagner, Johanna C Bendell, et al.Pageof 16